drugset / Trial / NCT00477269
Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the safety, tolerability, and efficacy of imatinib mesylate in patients with pulmonary arterial hypertension
Timeline
- Start
- 2006-04
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Imatinib | Small molecule | 400 mg | Oral |